Black Diamond Therapeutics (BDTX)
(Delayed Data from NSDQ)
$3.75 USD
+0.09 (2.46%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $3.74 -0.01 (-0.27%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (73 out of 252)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.14 | 1.37 | 9.99 |
Current Quarter Estimate | -0.35 | 2.88 | 61.00 |
Year Ago Quarter Estimate | -0.45 | -4.93 | 54.84 |
Next Quarter Estimate | -0.33 | 3.66 | 63.00 |
Next Year Estimate | -1.45 | 23.73 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 26.60 | 17.60 | 15.67 |
Next Year | -5.07 | 10.00 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.83 |
Price/Book (MRQ) | 1.85 | 2.03 |
Price/Cash Flow (MRFY) | NA | 16.44 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -163.24% |
Return on Equity (TTM) | -69.08% | -61.40% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.